Inhibition of PI3K/mTOR Pathways In Glioblastoma and Implications for Combination Therapy with Erlotinib, Temozolomide, and Radiation

被引：0
|
作者：
Prasad, G. [1 ]
Sottero, T. [1 ]
Yang, X. [1 ]
Mueller, S. [1 ]
James, D. [1 ]
Berger, M. [1 ]
Aftab, D. T. [2 ]
Prados, M. D. [1 ]
Haas-Kogan, D. A. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Exelixis Inc, San Francisco, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2009.07.172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [21] Taxifolin Targets PI3K and mTOR and Inhibits Glioblastoma Multiforme
    Yao, Weiqi
    Gong, Hongyun
    Mei, Heng
    Shi, Lei
    Yu, Jinming
    Hu, Yu
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [22] THE PI3K/MTOR PATHWAY CONTRIBUTES TO SEX DIFFERENCES IN GLIOBLASTOMA
    Sponagel, Jasmin
    Yu, Kwanha
    Ippolito, Joseph
    Deneen, Benjamin
    Rubin, Josh
    NEURO-ONCOLOGY, 2018, 20 : 90 - 90
  • [23] Inhibition of mTOR, but not PI3K, is required for the anti-tumor efficacy in breast cancer of dual PI3K/mTOR inhibitors given in combination with MEK inhibitors
    Smith, Aleisha M.
    Xiong, Jessie
    Hunter, Lucas
    Jordan, Jamie
    Clark, Kelly
    Darr, David B.
    Norman, Sharpless
    Perou, Charles M.
    Kim, William Y.
    CANCER RESEARCH, 2015, 75
  • [24] Dual PI3K and mTOR Inhibition in Waldenstrom Macroglobulinemia
    Husu, E. N.
    Roccaro, A. M.
    Anderson, K. C.
    Ghobrial, I. M.
    Leleu, X.
    Sacco, A.
    Melhem, M. R.
    Azab, A. K.
    Jia, X.
    Ngo, H. T.
    Azab, F.
    Runnels, J.
    Quang, P.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S144 - S145
  • [25] Targeting PI3K/mTOR/MAPK pathway in inhibition of cell growth and dissemination of glioblastoma multiforme
    Shannon, Craig M.
    Mohan, Avinash
    Braun, Alex
    Murali, Raj
    Jhanwar-Uniyal, Meena
    CANCER RESEARCH, 2011, 71
  • [26] Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations
    Rittler, Dominika
    Molnar, Eszter
    Baranyi, Marcell
    Garay, Tamas
    Hegedus, Luca
    Aigner, Clemens
    Tovari, Jozsef
    Timar, Jozsef
    Hegedus, Balazs
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 18
  • [27] Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways
    Dong, Pingping
    Hao, Fengmei
    Dai, Shufeng
    Tian, Lin
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2018, 38 (01) : 83 - 88
  • [28] PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response
    Li, Jie
    Kaneda, Megan M.
    Ma, Jun
    Li, Ming
    Shepard, Ryan M.
    Patel, Kunal
    Koga, Tomoyuki
    Sarver, Aaron
    Furnari, Frank
    Xu, Beibei
    Dhawan, Sanjay
    Ning, Jianfang
    Zhu, Hua
    Wu, Anhua
    You, Gan
    Jiang, Tao
    Venteicher, Andrew S.
    Rich, Jeremy N.
    Glass, Christopher K.
    Varner, Judith A.
    Chen, Clark C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (16)
  • [29] Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
    Qingfang Li
    Zhihui Li
    Ting Luo
    Huashan Shi
    Molecular Biomedicine, 3
  • [30] Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
    Li, Qingfang
    Li, Zhihui
    Luo, Ting
    Shi, Huashan
    MOLECULAR BIOMEDICINE, 2022, 3 (01):
12345